Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Current Assets (2020 - 2025)

Agilon Health (AGL) has disclosed Current Assets for 6 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 13.07% year-over-year to $1.3 billion, compared with a TTM value of $1.5 billion through Dec 2024, down 1.51%, and an annual FY2025 reading of $1.3 billion, down 13.07% over the prior year.
  • Current Assets was $1.3 billion for Q4 2025 at Agilon Health, down from $1.5 billion in the prior quarter.
  • Across five years, Current Assets topped out at $2.0 billion in Q1 2024 and bottomed at -$3.3 million in Q3 2024.
  • Average Current Assets over 5 years is $1.4 billion, with a median of $1.5 billion recorded in 2021.
  • The sharpest move saw Current Assets surged 364.72% in 2021, then tumbled 100.17% in 2024.
  • Year by year, Current Assets stood at $1.4 billion in 2021, then increased by 6.15% to $1.5 billion in 2022, then rose by 1.98% to $1.5 billion in 2023, then fell by 1.51% to $1.5 billion in 2024, then fell by 13.07% to $1.3 billion in 2025.
  • Business Quant data shows Current Assets for AGL at $1.3 billion in Q4 2025, $1.5 billion in Q4 2024, and -$3.3 million in Q3 2024.